Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionGryphon Financial Partners LLC
Latest Disclosed Ownership2,977 shares
Latest Disclosed Value $ 238,399
Gryphon Financial Partners LLC reports 2.20% decrease in ownership of EW / Edwards Lifesciences Corporation

On May 6, 2026 - Gryphon Financial Partners LLC filed a 13F-HR form disclosing ownership of 2,977 shares of Edwards Lifesciences Corporation (MX:EW) valued at $238,399 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 8, 2026 disclosing 3,044 shares of Edwards Lifesciences Corporation. This represents a change in shares of -2.20% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,977 -67 -2.20 238 -8.11 0.0190
2026-01-08 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 3,044 -38 -1.23 260 8.37 0.0278
2025-11-12 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 3,082 336 12.24 240 11.68 0.0273
2025-08-07 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,746 2,746 215 0.0280
2025-05-12 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 0 -2,946 -100.00 0 -100.00
2025-02-06 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,946 -1,374 -31.81 218 -23.51 0.0312
2024-11-08 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 4,320 -365 -7.79 285 -34.03 0.0385
2024-08-07 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 4,685 -457 -8.89 433 -12.02 0.0648
2024-05-01 2024-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 5,142 -1,312 -20.33 491 -27.79 0.0817
2024-02-13 2023-12-31 13F/A-1 EDWARDS LIFESCIENCES COM 28176E108 6,454 1,698 35.70 681 106.69 0.1203
2024-02-06 2023-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 6,454 1,698 681 0.0475
2023-11-07 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 4,756 3,432 259.21 329 165.32 0.0764
2023-08-08 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 1,324 -3,616 -73.20 125 -69.61 0.0270
2023-05-03 2023-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 4,940 5 0.10 409 10.87 0.0930
2023-02-08 2022-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 4,935 157 3.29 368 -6.84 0.0876
2022-11-14 2022-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 4,778 -165 -3.34 395 -15.96 0.0995
2022-07-28 2022-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 4,943 365 7.97 470 -12.64 0.1141
2022-05-05 2022-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 4,578 -698 -13.23 538 -21.35 0.1096
2022-02-01 2021-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 5,276 -409 -7.19 684 6.38 0.1296
2021-11-12 2021-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 5,685 -571 -9.13 643 23.65 0.1428
2021-08-13 2021-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 6,256 126 2.06 520 1.56 0.1170
2021-05-05 2021-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 6,130 -18 -0.29 512 -8.73 0.1163
2021-02-10 2020-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 6,148 -11 -0.18 561 14.02 0.1445
2020-11-16 2020-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 6,159 -24 -0.39 492 14.95 0.1454
2020-08-13 2020-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 6,183 3,581 137.62 428 -12.83 0.1327
2020-05-05 2020-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,602 -195 -6.97 491 -24.81 0.1808
2020-02-06 2019-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,797 16 0.58 653 6.87 0.1694
2019-11-07 2019-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,781 -54 -1.90 611 16.60 0.1763
2019-08-09 2019-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,835 -36 -1.25 524 -4.73 0.1508
2019-05-07 2019-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,871 0 0.00 550 25.00 0.1622
2019-02-11 2018-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,871 -54 -1.85 440 -13.56 0.1119
2018-11-06 2018-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,925 2,696 1,177.29 509 1,397.06 0.1519
2018-08-14 2018-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 229 0 0.00 34 6.25 0.0153
2018-05-14 2018-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 229 -14 -5.76 32 18.52 0.0164
2018-02-09 2017-12-31 13F EDWARDS LIFESCIENCES COR COM 28176E108 243 243 27 0.0154
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.